Lumps under the skin and lipohypertrophy
Injecting into the same patch builds firm areas that absorb insulin slowly and unpredictably. How to find them, and why moving to fresh skin needs planning.
Injecting into the same small patch of skin for long enough changes it. Firm, slightly rubbery areas build up under the surface, and insulin put into them absorbs slowly and unpredictably. It is extremely common, it is not a sign of doing anything wrong, and it is one of the more fixable causes of glucose that will not behave.
- The proper name is lipohypertrophy. It is a build-up of fatty tissue where insulin has been delivered repeatedly.
- Insulin into a lump can be slow, partial or delayed, and the same dose can behave differently on different days.
- You usually have to feel for it rather than look. The skin can appear completely normal.
- Moving to fresh skin can make insulin work noticeably better, which is why any change is one to make with your team.
- It moves glucose both ways: insulin that does not arrive properly leaves glucose higher and can make it rise for no reason you can see, while switching back to healthy skin lowers it, since more of each dose now lands. A hypo can follow at the time or shortly after, and again hours later including overnight.
- Lumps improve if the area is rested, though it takes months rather than days.
Why repeated injecting changes the tissue
Insulin is a growth signal as well as a glucose signal, and delivering it into the same spot repeatedly encourages fat cells there to grow. Over months that produces a firmer, slightly raised area under the skin. It is not scar tissue and it is not damage in the alarming sense: it is the tissue responding to being asked to absorb insulin over and over in one place.
It is very common, and there is nothing careless about it. Everybody has favourite spots, some places are easier to reach, some hurt less, and the habit forms without anyone deciding on it. Pumps concentrate the problem because a set stays in one place for days at a time.
The reason it matters is absorption. Insulin delivered into affected tissue can go in slowly, or partially, or unpredictably from one day to the next, and that unpredictability is worse than a consistently slow site. A dose that works on Monday and does very little on Wednesday, with nothing else changed, is exactly the pattern this produces.
Feeling for it, because looking is not enough
Most lipohypertrophy is felt rather than seen. Run your fingers flat over the areas you use, comparing one side with the other, and you are looking for a patch that feels firmer, thicker or more rubbery than the skin around it. Pinching the area gently can make it more obvious. It is often painless, which is part of why it goes unnoticed.
A useful clue is that affected areas frequently hurt less to inject into, because the nerve endings are less sensitive there. So the spot that is most comfortable can be the one that is absorbing worst, which is an unfortunate arrangement and worth knowing about, because comfort quietly steers people back to the same patch.
Your diabetes team should be checking your sites, and it is entirely reasonable to ask them to if it has not happened. They will feel areas you cannot reach or see easily, and they do this often enough to notice changes you would not.
Resting the area, and why the change needs your team
The fix is to stop using the affected area and let it recover, while spreading future injections or sets properly across the space you have. Recovery is slow, months rather than weeks, and the lump may not vanish entirely, but absorption generally improves well before it looks different.
Here is the important part, and it is a safety point rather than a formality. If insulin has been going into tissue that absorbs badly, moving to healthy skin means more of each dose actually arrives. The same numbers can suddenly do considerably more, and unexpected lows are a real and recognised risk when people switch to fresh sites. That is precisely why this is a change to plan with your diabetes team rather than to make quietly on a Monday morning.
Prevention is the ordinary answer afterwards: use the whole area available, move on a system rather than by feel, and change needles or sets as often as you are supposed to. Reusing needles makes lumps more likely, which is one of the more concrete reasons the single-use advice exists.
What makes it more likely
Time is the biggest factor, so someone twenty years in has had far more opportunity than someone diagnosed last year. Larger daily amounts concentrate more insulin into the same tissue. And the single most avoidable contributor is a small rotation area: using a genuinely wide spread, rather than shuffling around inside one patch, is what actually prevents it.
How it shows up
Examples, not instructions or doses.
The same breakfast and the same amount behaves completely differently across the week, with no illness or change to explain it. Erratic absorption from one area does that, and it is more confusing than a site that is simply slow.
One spot barely stings, so it has quietly become the default for a year. Reduced sensation is a sign of the tissue having changed, not a sign it is a good site.
You switch to fresh skin and start going low on numbers that were fine. More of each dose is arriving now, which is exactly why the move is planned with your team rather than made alone.